What is CONMED's investing cash flow?

CONMED (CNMD) reported investing cash flow of $4.11M in Q1 2026.

How has CONMED's investing cash flow changed year-over-year?

CONMED's investing cash flow increased by 240.3% year-over-year, from -$2.93M to $4.11M.

What is the long-term trend for CONMED's investing cash flow?

Over 4 years (2021 to 2025), CONMED's investing cash flow has grown at a 9.0% compound annual growth rate (CAGR), from -$14.87M to -$20.96M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

CONMED CNMD Investing Cash Flow

Investing Cash Flow at other companies

Johnson & JohnsonJNJ

-$1.04B-250%

StrykerSYK

-$185M+95.5%

Boston ScientificBSX

-$591M-18.2%

VericelVCEL

-$4.2M+72.3%

OSI SystemsOSIS

-$7.03M+20.9%

Zimmer Biomet HoldingsZBH

-$159M-50.0%

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.04B-35.6%

Enterprise value$1.87B-24.5%

P/E19×+5.4×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's investing cash flow?: CONMED (CNMD) reported investing cash flow of $4.11M in Q1 2026.
How has CONMED's investing cash flow changed year-over-year?: CONMED's investing cash flow increased by 240.3% year-over-year, from -$2.93M to $4.11M.
What is the long-term trend for CONMED's investing cash flow?: Over 4 years (2021 to 2025), CONMED's investing cash flow has grown at a 9.0% compound annual growth rate (CAGR), from -$14.87M to -$20.96M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.